179 related articles for article (PubMed ID: 18351386)
1. Presence of HIF-1 and related genes in normal mucosa, adenomas and carcinomas of the colorectum.
Greijer AE; Delis-van Diemen PM; Fijneman RJ; Giles RH; Voest EE; van Hinsbergh VW; Meijer GA
Virchows Arch; 2008 May; 452(5):535-44. PubMed ID: 18351386
[TBL] [Abstract][Full Text] [Related]
2. Stromal expression of hypoxia regulated proteins is an adverse prognostic factor in colorectal carcinomas.
Cleven AH; van Engeland M; Wouters BG; de Bruïne AP
Cell Oncol; 2007; 29(3):229-40. PubMed ID: 17452775
[TBL] [Abstract][Full Text] [Related]
3. Expression of hypoxia-inducible factor 1 alpha in thyroid carcinomas.
Burrows N; Resch J; Cowen RL; von Wasielewski R; Hoang-Vu C; West CM; Williams KJ; Brabant G
Endocr Relat Cancer; 2010 Mar; 17(1):61-72. PubMed ID: 19808899
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of carbonic anhydrase and HIF-1α in Wilms tumours.
Dungwa JV; Hunt LP; Ramani P
BMC Cancer; 2011 Sep; 11():390. PubMed ID: 21910893
[TBL] [Abstract][Full Text] [Related]
5. Increased activation of the hypoxia-inducible factor pathway in varicose veins.
Lim CS; Kiriakidis S; Paleolog EM; Davies AH
J Vasc Surg; 2012 May; 55(5):1427-39. PubMed ID: 22277691
[TBL] [Abstract][Full Text] [Related]
6. Risk prediction for malignant conversion of oral epithelial dysplasia by hypoxia related protein expression.
Zhang X; Han S; Han HY; Ryu MH; Kim KY; Choi EJ; Cha IH; Kim J
Pathology; 2013 Aug; 45(5):478-83. PubMed ID: 23811806
[TBL] [Abstract][Full Text] [Related]
7. HIF-1α and CA-IX as predictors of locoregional control for determining the optimal treatment modality for early-stage laryngeal carcinoma.
Kwon OJ; Park JJ; Ko GH; Seo JH; Jeong BK; Kang KM; Woo SH; Kim JP; Hwa JS; Carey TE
Head Neck; 2015 Apr; 37(4):505-10. PubMed ID: 24677746
[TBL] [Abstract][Full Text] [Related]
8. Correlation of expression of hypoxia-related proteins with prognosis in oral squamous cell carcinoma patients.
Eckert AW; Kappler M; Schubert J; Taubert H
Oral Maxillofac Surg; 2012 Jun; 16(2):189-96. PubMed ID: 22592457
[TBL] [Abstract][Full Text] [Related]
9. Prognostic assessment of hypoxia and metabolic markers in cervical cancer using automated digital image analysis of immunohistochemistry.
Kim BW; Cho H; Chung JY; Conway C; Ylaya K; Kim JH; Hewitt SM
J Transl Med; 2013 Aug; 11():185. PubMed ID: 23927384
[TBL] [Abstract][Full Text] [Related]
10. The basal epithelial marker P-cadherin associates with breast cancer cell populations harboring a glycolytic and acid-resistant phenotype.
Sousa B; Ribeiro AS; Nobre AR; Lopes N; Martins D; Pinheiro C; Vieira AF; Albergaria A; Gerhard R; Schmitt F; Baltazar F; Paredes J
BMC Cancer; 2014 Oct; 14():734. PubMed ID: 25269858
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-inducible factor 1 promotes chemoresistance of lung cancer by inducing carbonic anhydrase IX expression.
Sowa T; Menju T; Chen-Yoshikawa TF; Takahashi K; Nishikawa S; Nakanishi T; Shikuma K; Motoyama H; Hijiya K; Aoyama A; Sato T; Sonobe M; Harada H; Date H
Cancer Med; 2017 Jan; 6(1):288-297. PubMed ID: 28028936
[TBL] [Abstract][Full Text] [Related]
12. The role of Hypoxia-inducible factor-1 α , glucose transporter-1, (GLUT-1) and carbon anhydrase IX in endometrial cancer patients.
Sadlecki P; Bodnar M; Grabiec M; Marszalek A; Walentowicz P; Sokup A; Zegarska J; Walentowicz-Sadlecka M
Biomed Res Int; 2014; 2014():616850. PubMed ID: 24745019
[TBL] [Abstract][Full Text] [Related]
13. VHL inactivation is an important pathway for the development of malignant sporadic pancreatic endocrine tumors.
Schmitt AM; Schmid S; Rudolph T; Anlauf M; Prinz C; Klöppel G; Moch H; Heitz PU; Komminoth P; Perren A
Endocr Relat Cancer; 2009 Dec; 16(4):1219-27. PubMed ID: 19690016
[TBL] [Abstract][Full Text] [Related]
14. Cytoplasmic location of factor-inhibiting hypoxia-inducible factor is associated with an enhanced hypoxic response and a shorter survival in invasive breast cancer.
Tan EY; Campo L; Han C; Turley H; Pezzella F; Gatter KC; Harris AL; Fox SB
Breast Cancer Res; 2007; 9(6):R89. PubMed ID: 18096060
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological implications of the expression of hypoxia-related proteins in gastric cancer.
Jung JH; Im S; Jung ES; Kang CS
Int J Med Sci; 2013; 10(9):1217-23. PubMed ID: 23935399
[TBL] [Abstract][Full Text] [Related]
16. Differential regulation of DEC2 among hypoxia-inducible genes in endometrial carcinomas.
Yunokawa M; Tanimoto K; Nakamura H; Nagai N; Kudo Y; Kawamoto T; Kato Y; Hiyama E; Hiyama K; Nishiyama M
Oncol Rep; 2007 Apr; 17(4):871-8. PubMed ID: 17342330
[TBL] [Abstract][Full Text] [Related]
17. Clinical impacts of mammalian target of rapamycin expression in human colorectal cancers.
Alqurashi N; Gopalan V; Smith RA; Lam AK
Hum Pathol; 2013 Oct; 44(10):2089-96. PubMed ID: 23773481
[TBL] [Abstract][Full Text] [Related]
18. Necrosis related HIF-1alpha expression predicts prognosis in patients with endometrioid endometrial carcinoma.
Seeber LM; Horrée N; van der Groep P; van der Wall E; Verheijen RH; van Diest PJ
BMC Cancer; 2010 Jun; 10():307. PubMed ID: 20565904
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of HIF-1 in glioblastoma multiforme and anaplastic astrocytoma.
Mayer A; Schneider F; Vaupel P; Sommer C; Schmidberger H
Int J Oncol; 2012 Oct; 41(4):1260-70. PubMed ID: 22825389
[TBL] [Abstract][Full Text] [Related]
20. Expression of von Hippel-Lindau tumor suppressor and tumor-associated carbonic anhydrases IX and XII in normal and neoplastic colorectal mucosa.
Kivela AJ; Parkkila S; Saarnio J; Karttunen TJ; Kivela J; Parkkila AK; Bartosova M; Mucha V; Novak M; Waheed A; Sly WS; Rajaniemi H; Pastorekova S; Pastorek J
World J Gastroenterol; 2005 May; 11(17):2616-25. PubMed ID: 15849821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]